GlassScriptPhysician profile
Sanjay J Khiani
NPI 1063605293
$1,709.94
in general payments reported to CMS, 2019-2025
16 companies · $345 in 2025
The $345 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219 · 2020: $256 · 2021: $236 · 2022: $302 · 2023: $215 · 2024: $137 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $697.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $696.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $367.78 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $342.44 | 2019-2025 | Tezspire, Airsupra |
| Novartis Pharmaceuticals Corporation | $151.54 | 2021-2025 | |
| Csl Behring | $137.68 | 2019-2022 | |
| Pharming Healthcare, INC. | $117.01 | 2023 | Joenja |
| Pfizer INC. | $109.45 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $107.14 | 2021-2022 | |
| Optinose US, INC. | $91.75 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $83.61 | 2020-2021 | |
| Glaxosmithkline, LLC. | $59.81 | 2019-2022 | |
| Phadia US INC. | $47.71 | 2019-2021 | |
| Alk-Abello, INC | $28.58 | 2019-2020 | |
| Genentech USA, INC. | $20.00 | 2021 | |
| Hikma Pharmaceuticals USA | $18.84 | 2022 | |
| Circassia INC. | $14.76 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Greer Laboratories, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sanjay Khiani listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.